menu
    • menu

    Company profile for Polfa Tarchomin

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatinous capsules; dry bottled syrups; sterile powders for injections in glass vials a...
    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatinous capsules; dry bottled syrups; sterile powders for injections in glass vials and liquids in glass ampoules; insulin cartridges; dermatological: aerosols, solutions, gels. Polfa Tarchomin will be in position to produce high-potency injectables (vials and prefilled syringes) in 2025.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Polfa TarchominPoland Flag
    Country
    Country
    Poland
    Address
    Address
    A. Fleminga 2 street, 03-176 Warsaw
    Telephone
    Telephone
    +48 225108333
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.polfa-tarchomin.com.pl/en/home/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/polfa-tarchomin/
    youtube
    YouTube
    https://www.youtube.com/@PolfaTarchominSA
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Distribution of PolhuminPen injectors
    Distribution of PolhuminPen injectors

    01 Dec 2025

    // PRESS RELEASE

    https://tzfpolfa.pl/en/news/availability-of-elenium/

    PRESS RELEASE
    01 Dec 2025
    Share Share
    Success in the development of the medicinal product Dapagliflozin
    Success in the development of the medicinal product Dapagliflozin

    23 Oct 2025

    // PRESS RELEASE

    https://tzfpolfa.pl/en/news/success-in-the-development-of-the-medicinal-product-dapagliflozinum-10-mg/

    PRESS RELEASE
    23 Oct 2025
    Share Share
    Center for Development and Production of Highly Potent Drugs
    Center for Development and Production of Highly Potent Drugs

    23 Oct 2025

    // PRESS RELEASE

    https://tzfpolfa.pl/en/news/the-center-for-development-and-production-of-highly-potent-drugs/

    PRESS RELEASE
    23 Oct 2025
    Share Share
    Request for quotation – RFQZ79/5914/1
    Request for quotation – RFQZ79/5914/1

    16 Oct 2025

    // PRESS RELEASE

    https://tzfpolfa.pl/en/news/request-for-quotation-rfqz79-5914-1-bioequivalence-study-empagliflozinum-25-mg-coated-tablets/

    PRESS RELEASE
    16 Oct 2025
    Share Share
    Announcement selection of audit firm external audit of project
    Announcement selection of audit firm external audit of project

    13 Sep 2024

    // PRESS RELEASE

    https://www.polfa-tarchomin.com.pl/ogloszenie-wybor-firmy-audytorskiej-audyt-zewnetrzny-projektu-opracowanie-i-rozwoj-nowej-postaci-farmaceutycznej-produktu-leczniczego/

    PRESS RELEASE
    13 Sep 2024
    Share Share
    Financing for the Construction of R&D Center & Modernization of the Laboratory
    Financing for the Construction of R&D Center & Modernization of the Laboratory

    07 Jul 2021

    // PRESS RELEASE

    https://www.polfa-tarchomin.com.pl/dofinansowania-na-budowe-centrum-badawczo-rozwojowego-oraz-modernizacje-laboratorium-do-kontroli-i-certyfikacji-masek-chirurgicznych/

    PRESS RELEASE
    07 Jul 2021
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Erythromycin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Erythromycin

    Poland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13409

    Submission : 1998-09-01

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Ifosfamide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Ifosfamide

    Poland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2006-238 - Rev 02

    Issue Date : 2024-08-02

    Type : Chemical

    Substance Number : 1529

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Disodium Pamidronate Pentahydrate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    04

    Zoledronic Acid

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    LISTED APIs

    read-more
    read-more
    Contact Supplier
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Erythromycin Cyclocarbonate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatino...
    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatinous capsules; dry bottled syrups; sterile powders for injections in glass vials and liquids in glass ampoules; insulin cartridges; dermatological: aerosols, solutions, gels. Polfa Tarchomin will be in position to produce high-potency injectables (vials and prefilled syringes) in 2025.
    blank

    01

    Erythromycin Cyclocarbonate

    Poland
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Erythromycin Cyclocarbonate

    Poland
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Polfa Tarchomin

    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatinous capsules; dry bottled syrups; sterile powders for injections in glass vials and liquids in glass ampoules; insulin cartridges; dermatological: aerosols, solutions, gels. Polfa Tarchomin will be in position to produce high-potency injectables (vials and prefilled syringes) in 2025.

    About the Company : Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infe...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ifosfamide

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatino...
    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatinous capsules; dry bottled syrups; sterile powders for injections in glass vials and liquids in glass ampoules; insulin cartridges; dermatological: aerosols, solutions, gels. Polfa Tarchomin will be in position to produce high-potency injectables (vials and prefilled syringes) in 2025.
    blank

    02

    Ifosfamide

    Poland
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Ifosfamide

    Poland
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Polfa Tarchomin

    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatinous capsules; dry bottled syrups; sterile powders for injections in glass vials and liquids in glass ampoules; insulin cartridges; dermatological: aerosols, solutions, gels. Polfa Tarchomin will be in position to produce high-potency injectables (vials and prefilled syringes) in 2025.

    About the Company : Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infe...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Pamidronate Disodium Pentahydrate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatino...
    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatinous capsules; dry bottled syrups; sterile powders for injections in glass vials and liquids in glass ampoules; insulin cartridges; dermatological: aerosols, solutions, gels. Polfa Tarchomin will be in position to produce high-potency injectables (vials and prefilled syringes) in 2025.
    blank

    03

    Pamidronate Disodium Pentahydrate

    Poland
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Pamidronate Disodium Pentahydrate

    Poland
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Polfa Tarchomin

    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatinous capsules; dry bottled syrups; sterile powders for injections in glass vials and liquids in glass ampoules; insulin cartridges; dermatological: aerosols, solutions, gels. Polfa Tarchomin will be in position to produce high-potency injectables (vials and prefilled syringes) in 2025.

    About the Company : Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infe...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zoledronic Acid

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatino...
    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatinous capsules; dry bottled syrups; sterile powders for injections in glass vials and liquids in glass ampoules; insulin cartridges; dermatological: aerosols, solutions, gels. Polfa Tarchomin will be in position to produce high-potency injectables (vials and prefilled syringes) in 2025.
    blank

    04

    Zoledronic Acid

    Poland
    PCC
    Not Confirmed
    arrow

    Zoledronic Acid

    Poland
    arrow
    PCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Polfa Tarchomin

    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatinous capsules; dry bottled syrups; sterile powders for injections in glass vials and liquids in glass ampoules; insulin cartridges; dermatological: aerosols, solutions, gels. Polfa Tarchomin will be in position to produce high-potency injectables (vials and prefilled syringes) in 2025.

    About the Company : Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infe...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Development Success for Dapagliflozinum 10 mg

    Details:

    Dapagliflozinum, a miscellaneous product targeting SGLT2, shows promise in treating undisclosed key focus area.


    Lead Product(s): Dapagliflozin

    Therapeutic Area: Endocrinology Brand Name: Dapagliflozinum-Generic

    Study Phase: Phase IProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable October 23, 2025

    blank

    01

    Polfa Tarchomin

    Poland
    arrow
    BPI Europe
    Not Confirmed

    Polfa Tarchomin

    Poland
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Dapagliflozin

    Therapeutic Area : Endocrinology

    Highest Development Status : Phase I

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Development Success for Dapagliflozinum 10 mg

    Details : Dapagliflozinum, a miscellaneous product targeting SGLT2, shows promise in treating undisclosed key focus area.

    Product Name : Dapagliflozinum-Generic

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    October 23, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDF Dossiers

    read-more
    read-more

    01

    Brand Name : Amotaks,

    Poland
    PCC
    Not Confirmed
    arrow

    Brand Name : Amotaks,

    Poland
    arrow
    PCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorised

    Registration Country : Malta

    Amoxicillin

    Polfa Tarchomin

    Dosage Form : Granule For Oral Suspens...

    Brand Name : Amotaks,

    Dosage Strength : 5ML

    Packaging :

    Approval Date : 2023-01-17

    Application Number :

    Regulatory Info : Authorised

    Registration Country : Malta

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : Taromentin,

    Poland
    PCC
    Not Confirmed
    arrow

    Brand Name : Taromentin,

    Poland
    arrow
    PCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorised

    Registration Country : Malta

    Amoxicillin Sodium; Clavulanate Potassium

    Polfa Tarchomin

    Dosage Form : Powder For Solution For ...

    Brand Name : Taromentin,

    Dosage Strength : 500MG; 100MG

    Packaging :

    Approval Date : 2025-03-18

    Application Number :

    Regulatory Info : Authorised

    Registration Country : Malta

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : Amotax

    Poland
    PCC
    Not Confirmed
    arrow

    Brand Name : Amotax

    Poland
    arrow
    PCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Approved

    Registration Country : Sweden

    Amoxicillin Trihydrate

    Polfa Tarchomin

    Dosage Form : Tablet

    Brand Name : Amotax

    Dosage Strength : 500mg

    Packaging :

    Approval Date : 14-10-2024

    Application Number : 2.02E+13

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : Amotax

    Poland
    PCC
    Not Confirmed
    arrow

    Brand Name : Amotax

    Poland
    arrow
    PCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Approved

    Registration Country : Sweden

    Amoxicillin Trihydrate

    Polfa Tarchomin

    Dosage Form : Tablet

    Brand Name : Amotax

    Dosage Strength : 750mg

    Packaging :

    Approval Date : 14-10-2024

    Application Number : 2.02E+13

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : Amotax

    Poland
    PCC
    Not Confirmed
    arrow

    Brand Name : Amotax

    Poland
    arrow
    PCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Approved

    Registration Country : Sweden

    Amoxicillin Trihydrate

    Polfa Tarchomin

    Dosage Form : Tablet

    Brand Name : Amotax

    Dosage Strength : 1g

    Packaging :

    Approval Date : 14-10-2024

    Application Number : 2.02E+13

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : N/A

    Poland
    Bioprocess International Europe
    Not Confirmed
    arrow

    Brand Name : N/A

    Poland
    arrow
    Bioprocess International Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Dossier Availability: Q3 2024

    Registration Country : Poland

    Amoxicillin Trihydrate; Clavulanic Acid

    Polfa Tarchomin

    Dosage Form : Powder for Oral Suspensi...

    Brand Name :

    Dosage Strength : 600MG; 42.9MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : Dossier Availability: Q3 2024

    Registration Country : Poland

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : Taromentin

    Poland
    PCC
    Not Confirmed
    arrow

    Brand Name : Taromentin

    Poland
    arrow
    PCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorised

    Registration Country : Malta

    Amoxicillin; Clavulanic Acid

    Polfa Tarchomin

    Dosage Form : Film Coated Tablet

    Brand Name : Taromentin

    Dosage Strength : 875MG; 125MG

    Packaging :

    Approval Date : 2022-09-12

    Application Number :

    Regulatory Info : Authorised

    Registration Country : Malta

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : Taromentin, (400

    Poland
    PCC
    Not Confirmed
    arrow

    Brand Name : Taromentin, (400

    Poland
    arrow
    PCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorised

    Registration Country : Malta

    Amoxicillin; Clavulanic Acid

    Polfa Tarchomin

    Dosage Form : Powder For Oral Suspensi...

    Brand Name : Taromentin, (400

    Dosage Strength : 80MG/ML; 11.4MG/ML

    Packaging :

    Approval Date : 2022-12-22

    Application Number :

    Regulatory Info : Authorised

    Registration Country : Malta

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : N/A

    Poland
    PCC
    Not Confirmed
    arrow

    Brand Name : N/A

    Poland
    arrow
    PCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Dossier Available

    Registration Country : Poland

    Ampicillin

    Polfa Tarchomin

    Dosage Form : Powder for Solution for ...

    Brand Name :

    Dosage Strength : 500MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : Dossier Available

    Registration Country : Poland

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : N/A

    Poland
    PCC
    Not Confirmed
    arrow

    Brand Name : N/A

    Poland
    arrow
    PCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : Poland

    Ampicillin

    Polfa Tarchomin

    Dosage Form : Powder for solution for ...

    Brand Name :

    Dosage Strength : 1000MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Poland

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Services

    Upload your portfolio for free, ask us

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Drug Product Manufacturing

    Click here to discover the service providers for Drug Product Manufacturing

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    Packaging

    Click here to discover the service providers for Packaging

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Polfa Tarchomin and get a quotation

    Polfa Tarchomin is a supplier offers 4 products (APIs, Excipients or Intermediates).

    Find a price of Erythromycin bulk with DMF offered by Polfa Tarchomin

    Find a price of Ifosfamide bulk with CEP offered by Polfa Tarchomin

    Find a price of Disodium Pamidronate Pentahydrate bulk offered by Polfa Tarchomin

    Find a price of Zoledronic Acid bulk offered by Polfa Tarchomin

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search